TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcoma.
TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcoma.
复制标题
DOI:
10.1016/j.ccell.2021.07.003
复制
发表时间:
2021-09-13
期刊:
影响因子:
50.3
通讯作者:
Stegmaier K
中科院分区:
文献类型:
--
作者:
Seong BKA;Dharia NV;Lin S;Donovan KA;Chong S;Robichaud A;Conway A;Hamze A;Ross L;Alexe G;Adane B;Nabet B;Ferguson FM;Stolte B;Wang EJ;Sun J;Darzacq X;Piccioni F;Gray NS;Fischer ES;Stegmaier K
Fusion-transcription factors (fusion-TFs) represent a class of driver oncoproteins that are difficult to therapeutically target. Recently, protein degradation has emerged as a strategy to target these challenging oncoproteins. The mechanisms that regulate fusion-TF stability, however, are generally unknown. Using CRISPR-Cas9 screening, we discovered tripartite motif-containing 8 (TRIM8) as an E3 ubiquitin ligase that ubiquitinates and degrades EWS/FLI, a driver fusion-TF in Ewing sarcoma. Moreover, we identified TRIM8 as a selective dependency in Ewing sarcoma compared with >700 other cancer cell lines. Mechanistically, TRIM8 knockout led to an increase in EWS/FLI protein levels that was not tolerated. EWS/FLI acts as a neomorphic substrate for TRIM8, defining the selective nature of the dependency. Our results demonstrate that fusion-TF protein stability is tightly regulated and highlight fusion oncoprotein-specific regulators as selective therapeutic targets. This study provides a tractable strategy to therapeutically exploit oncogene overdose in Ewing sarcoma and potentially other fusion-TF-driven cancers. The E3 ligase TRIM8 is an exquisitely selective dependency in Ewing sarcoma TRIM8 regulates EWS/FLI expression but not its wild-type counterparts K334 is critical for TRIM8-mediated degradation of EWS/FLI Increased EWS/FLI levels induce cell death in Ewing sarcoma cells Using CRISPR-Cas9 screens, Seong et al. demonstrate that the E3 ligase TRIM8 degrades the EWS/FLI fusion oncoprotein in Ewing sarcoma cells. Knockout of TRIM8 is selectively lethal in Ewing sarcoma compared with >700 non-Ewing cancer models. TRIM8 loss increases EWS/FLI protein levels, which is toxic to Ewing sarcoma cells.
登录
查看更多内容
影响因子:
46.9
作者:
Doench JG;Fusi N;Sullender M;Hegde M;Vaimberg EW;Donovan KF;Smith I;Tothova Z;Wilen C;Orchard R;Virgin HW;Listgarten J;Root DE
通讯作者:
Root DE
DOI:
10.1073/pnas.1110946108
发表时间:
2011-11-29
影响因子:
11.1
作者:
Li, Qi;Yan, Jie;Wang, Yan-Yi
通讯作者:
Wang, Yan-Yi
影响因子:
64.8
作者:
Gorthi A;Romero JC;Loranc E;Cao L;Lawrence LA;Goodale E;Iniguez AB;Bernard X;Masamsetti VP;Roston S;Lawlor ER;Toretsky JA;Stegmaier K;Lessnick SL;Chen Y;Bishop AJR
通讯作者:
Bishop AJR
影响因子:
30.8
作者:
Dharia NV;Kugener G;Guenther LM;Malone CF;Durbin AD;Hong AL;Howard TP;Bandopadhayay P;Wechsler CS;Fung I;Warren AC;Dempster JM;Krill-Burger JM;Paolella BR;Moh P;Jha N;Tang A;Montgomery P;Boehm JS;Hahn WC;Roberts CWM;McFarland JM;Tsherniak A;Golub TR;Vazquez F;Stegmaier K
通讯作者:
Stegmaier K
DOI:
10.1038/s41571-018-0113-0
发表时间:
2018-12
期刊:
Nature reviews. Clinical oncology
影响因子:
--
作者:
Cocco E;Scaltriti M;Drilon A
通讯作者:
Drilon A